How and where to order Lamictal (Lamotrigine) 25 mg, 50 mg, 100 mg, 200 mg tablets online:

Shop:MEDS FOR SALE - 5% discount coupon 5OFF
Prices:from $0.78 per pill
Forms:Lamotrigine 25, 50, 100, 200 mg tablets
Quantity:30-360 pills
Type:Lamotrigine brand, Lamictal generic
Payment:Visa, Mastercard, AmEx, Bitcoin
Delivery:Regular and express mail service
Shipping:Worldwide, including USA, UK, Europe, Canada, Australia

Indications and usage:

Lamictal (Lamotrigine) is indicated for:

  • epilepsy-adjunctive therapy in patients aged 2 years and older:
    - partial-onset seizures.
    - primary generalized tonic-clonic seizures.
    - generalized seizures of Lennox-Gastaut syndrome.
  • epilepsy-monotherapy in patients aged 16 years and older: conversion to monotherapy in patients with partial-onset seizures who are receiving treatment with carbamazepine, phenytoin, phenobarbital, primidone, or valproate as the single antiepileptic drug.
  • bipolar disorder: maintenance treatment of bipolar I disorder to delay the time to occurrence of mood episodes in patients treated for acute mood episodes with standard therapy.
  • trigeminal neuralgia
  • peripheral neuropathy
  • neuropathic pain
  • cluster headaches
  • migraines
  • visual snow
  • schizophrenia
  • schizoaffective disorder
  • anxiety
  • depression
  • depersonalization disorder
  • hallucinogen persisting perception disorder
  • borderline personality disorder
  • cyclothymic disorder
  • obsessive-compulsive disorder
  • restless legs syndrome
  • post-traumatic stress disorder (PTSD)

    Limitations of use: treatment of acute manic or mixed episodes is not recommended. effectiveness of Lamictal in the acute treatment of mood episodes has not been established.

    Dosage and administration:

  • Dosing is based on concomitant medications, indication, and patient age.
  • To avoid an increased risk of rash, the recommended initial dose and subsequent dose escalations should not be exceeded. Lamictal Starter Kits and Lamictal ODT Patient Titration Kits are available for the first 5 weeks of treatment.
  • Do not restart Lamictal in patients who discontinued due to rash unless the potential benefits clearly outweigh the risks.
  • Adjustments to maintenance doses will be necessary in most patients starting or stopping estrogen-containing oral contraceptives.
  • Discontinuation: taper over a period of at least 2 weeks (approximately 50% dose reduction per week).

    Dosage forms and strengths:

  • Lamictal (Lamotrigine) tablets scored 25 mg, 100 mg, 150 mg, 200 mg.
  • Lamictal (Lamotrigine) tablets for oral suspension 2 mg, 5 mg, 25 mg.
  • Lamictal ODT (Lamotrigine) orally disintegrating tablets 25 mg, 50 mg, 100 mg, 200 mg.


    Overdosage experience

    Overdoses involving quantities up to 15 g have been reported for Lamictal pills, some of which have been fatal. Overdose has resulted in ataxia, nystagmus, seizures (including tonic-clonic seizures), decreased level of consciousness, coma, and intraventricular conduction delay.

    Management of overdosage

    There are no specific antidotes for lamotrigine. Following a suspected overdose, hospitalization of the patient is advised. General supportive care is indicated, including frequent monitoring of vital signs and close observation of the patient. If indicated, emesis should be induced; usual precautions should be taken to protect the airway. It should be kept in mind that immediate-release lamotrigine is rapidly absorbed. It is uncertain whether hemodialysis is an effective means of removing lamotrigine from the blood. In 6 renal failure patients, about 20% of the amount of lamotrigine in the body was removed by hemodialysis during a 4-hour session. A Poison Control Center should be contacted for information on the management of overdosage of Lamotrigine (Lamictal) pills.


    Hypersensitivity to lamotrigine or ingredients of Lamictal tablets.

    Warnings and precautions:

  • Life-threatening serious rash and/or rash-related death: discontinue at the first sign of rash, unless the rash is clearly not drug related.
  • Hemophagocytic lymphohistiocytosis: consider this diagnosis and evaluate patients immediately if they develop signs or symptoms of systemic inflammation. Discontinue Lamictal if an alternative etiology is not established.
  • Fatal or life-threatening hypersensitivity reaction: multiorgan hypersensitivity reactions, also known as drug reaction with eosinophilia and systemic symptoms, may be fatal or life threatening. Early signs may include rash, fever, and lymphadenopathy. These reactions may be associated with other organ involvement, such as hepatitis, hepatic failure, blood dyscrasias, or acute multiorgan failure. Lamictal should be discontinued if alternate etiology for this reaction is not found.
  • Cardiac rhythm and conduction abnormalities: based on in vitro findings, Lamotrigine could cause serious arrhythmias and/or death in patients with certain underlying cardiac disorders or arrhythmias. Any expected or observed benefit of this medication in an individual patient with clinically important structural or functional heart disease must be carefully weighed against the risk for serious arrythmias and/or death for that patient.
  • Blood dyscrasias (e.g., neutropenia, thrombocytopenia, pancytopenia): may occur, either with or without an associated hypersensitivity syndrome. Monitor for signs of anemia, unexpected infection, or bleeding.
  • Suicidal behavior and ideation: monitor for suicidal thoughts or behaviors.
  • Aseptic meningitis: monitor for signs of meningitis.
  • Medication errors due to product name confusion: strongly advise patients to visually inspect tablets to verify the received drug is correct.

    Adverse reactions, side effects:

  • Epilepsy: most common adverse reactions (incidence >= 10%) in adults were headache, dizziness, diplopia, ataxia, nausea, blurred vision, somnolence, rhinitis, pharyngitis, and rash. Additional adverse reactions (incidence >= 10%) reported in children included vomiting, infection, fever, accidental injury, diarrhea, abdominal pain, and tremor.
  • Bipolar disorder: most common adverse reactions (incidence > 5%) in adults were nausea, insomnia, somnolence, back pain, fatigue, rash, rhinitis, abdominal pain, and xerostomia.

    To report suspected adverse reactions of Lamictal (Lamotrigine) tablets, contact GlaxoSmithKline pharmaceutical company or your local FDA.

    Drug interactions:

  • Valproate increases lamotrigine concentrations more than 2-fold.
  • Carbamazepine, phenytoin, phenobarbital, primidone, and rifampin decrease lamotrigine concentrations by approximately 40%.
  • Estrogen-containing oral contraceptives decrease lamotrigine concentrations by approximately 50%.
  • Protease inhibitors lopinavir/ritonavir and atazanavir/lopinavir decrease lamotrigine exposure by approximately 50% and 32%, respectively.
  • Coadministration with organic cationic transporter 2 substrates with narrow therapeutic index is not recommended.

    Related medications:

  • Lyrica 150 mg
  • Levetiracetam 250 mg tablets

    Use in specific populations:


    Based on animal data may cause fetal harm.


    Lamotrigine is present in milk from lactating women taking Lamictal tablets.

    Pediatric use

    This medicine is indicated as adjunctive therapy in patients aged 2 years and older for partial-onset seizures, the generalized seizures of Lennox-Gastaut syndrome, and PGTC seizures.

    Geriatric use

    Clinical trials of Lamotrigine (Lamictal) for epilepsy and bipolar disorder did not include sufficient numbers of patients aged 65 years and older to determine whether they respond differently from younger patients or exhibit a different safety profile than that of younger patients.

    Hepatic impairment

    Dosage adjustments required in patients with moderate and severe liver impairment.

    Renal impairment

    Reduced maintenance doses may be effective for patients with significant renal impairment.

    Where to buy lamotrigine online:

    To purchase Lamictal (Lamotrigine) 25 mg, 50 mg, 100 mg, 200 mg tablets from reliable online pharmacies and drugstores at low prices please use resources described above on this webpage.

    Here is a list of popular medications containing lamotrigine as a main active pharmaceutical ingredient; their trade names, forms, doses, companies - manufacturers, distributors, suppliers, researchers and developers:

    Trade name of the drug Pharmaceutical forms and doses Companies
  • Tablets, Chewable; Oral; Lamotrigine 5 mg, 25 mg, 50 mg, 100 mg, 200 mg
  • Tablets, Dispersible; Oral; Lamotrigine 2 mg
  • Tablets, Film-Coated; Oral; Lamotrigine 50 mg, 100 mg
  • Tablets, Orally Disintegrating; Oral; Lamotrigine 5 mg, 25 mg, 50 mg, 100 mg, 200 mg
  • Tablets; Oral; Lamotrigine 2 mg, 5 mg, 25 mg, 50 mg, 100 mg, 150 mg, 200 mg, 250 mg
  • HLS Therapeutics
  • Novartis
  • Viatris
  • Lamictal ODT
  • Tablets, Orally Disintegrating; Oral; Lamotrigine 25 mg, 50 mg, 100 mg, 200 mg
  • Novartis
  • Lamictal XR
  • Tablets, Extended Release; Oral; 25 mg, 50 mg, 100 mg, 200 mg, 250 mg, 300 mg
  • Sun Pharmaceutical Industries
  • Lamitor
  • Tablets; Oral; Lamotrigine 25 mg, 50 mg, 100 mg
  • Teva
  • IVAX
  • Mylan-Lamotrigine
  • Tablets; Oral; Lamotrigine 25 mg, 50 mg, 100 mg, 150 mg, 200 mg
  • Teva
  • IVAX

  • Online Appointment Form

    One of the most sublime experiences we can ever have is to wake up feeling healthy after we have been sick. Contact us, we can help feel healthy.

    • Mailing Address:
      10 Congress Street,
      Suite 505 Pasadena,
      California 91105

    • Phone: 626-792-7300

    • Fax: 626-792-7336

    • Email: [email protected]

    • or fill in the form on our contact page